Business

GoodRx Reports First Quarter 2025 Results

First Quarter 2025 Revenue In-line; Adjusted EBITDA Margin Beats Previous Guidance; Maintains Full Year 2025 Revenue Guidance Range; Raises Adjusted EBITDA

articleGoodrx Holdings, Inc.May 7, 20254/company/goodrx-holdings-inc/news/goodrx-reports-first-quarter-2025-results-2025-05-07
GoodRx Reports First Quarter 2025 Results

About this update from Goodrx Holdings, Inc.

[{"type":"text","content":"\nFirst Quarter 2025 Revenue In-line; Adjusted EBITDA Margin Beats Previous Guidance; Maintains Full Year 2025 Revenue Guidance Range; Raises Adjusted EBITDA Expectations\n\n SANTA MONICA, Calif.--(BUSINESS WIRE)--\nGoodRx Holdings, Inc. (Nasdaq: GDRX) (\"we,\" \"us,\" \"our,\" “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2025.\n\nFirst Quarter 2025 Highlights\n\n\nRevenue of $203.0 million\n\n\nNet income of $11.1 million; Net income margin of 5.4%\n\n\nAdjusted Net Income1 of $34.4 million; Adjusted Net Income Margin1 of 16.9%\n\n\nAdjusted EBITDA1 of $69.8 million; Adjusted EBITDA Margin1 of 34.4%\n\n\nNet cash provided by operating activities of $9.4 million\n\n\nExited the quarter with over 7 million consumers of prescription-related offerings2\n\n\n“Since stepping into this role, I have dedicated my time strengthening our leadership team, gaining a deeper understanding of our business, meeting with key partners, understanding the macroeconomic environment, and identifying key capabilities and growth opportunities,” said Wendy Barnes, Chief Executive Officer and President of GoodRx. “I can confidently say that we are in a very strong position to deliver meaningful value across the pharmacy ecosystem. Furthermore, we are focused on high-impact initiatives that we believe will drive our business forward in compelling ways.”\n\n\n\n1\n\n\n\n\nAdjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, and Adjusted Net Income Margin are non-GAAP financial measures and are presented for supplemental informational purposes only. Adjusted EBITDA Margin and Adjusted Net Income Margin are defined as Adjusted EBITDA and Adjusted Net Income, respectively, divided by Adjusted Revenue. Refer to the Non-GAAP Financial Measures section below for definitions, additional information, and reconciliations to the most directly comparable GAAP measures.\n\n\n\n\n\n2\n\n\n\n\nSum of Monthly Active Consumers (MACs) for Q1'25 and subscribers to our subscription plans as of March 31, 2025. Refer to Key Operating Metrics below for definitions of Monthly Active Consumers and subscription plans.\n\n\n\n\nFirst Quarter 2025 Financial Overview (all comparisons are made to the same period of the prior year unless otherwise noted):\n\nRevenue increased 3...

More updates from Goodrx Holdings, Inc.